Literature DB >> 9858242

R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.

K Furuyama1, R Uno, A Urabe, N Hayashi, H Fujita, M Kondo, S Sassa, M Yamamoto.   

Abstract

A R411C missense mutation of the erythroid-specific delta-aminolaevulinate synthase (ALAS2) gene was identified in a pedigree with X-linked pyridoxine-responsive sideroblastic anaemia (XLSA). The normal and the mutant cDNAs were expressed in E. coli, and the enzyme protein was purified. ALAS activity of the mutant enzyme was 12% and 25%, when incubated in the absence and the presence of pyridoxal 5'-phosphate, respectively, compared with that of the wild-type enzyme. These findings suggest that the R411C mutation accounts for low ALAS activity and a partial pyridoxine-responsiveness of the disease in the patient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858242     DOI: 10.1046/j.1365-2141.1998.01050.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.

Authors:  Kazumichi Furuyama; Kiriko Kaneko
Journal:  Int J Hematol       Date:  2017-11-14       Impact factor: 2.490

2.  Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia.

Authors:  K Furuyama; S Sassa
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  Sideroblastic anemia: functional study of two novel missense mutations in ALAS2.

Authors:  Manuel Méndez; María-Isabel Moreno-Carralero; Marta Morado-Arias; María-Cristina Fernández-Jiménez; Silvia de la Iglesia Iñigo; María-José Morán-Jiménez
Journal:  Mol Genet Genomic Med       Date:  2016-01-13       Impact factor: 2.183

4.  Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).

Authors:  Rie Ohba; Kazumichi Furuyama; Kenichi Yoshida; Tohru Fujiwara; Noriko Fukuhara; Yasushi Onishi; Atsushi Manabe; Etsuro Ito; Keiya Ozawa; Seiji Kojima; Seishi Ogawa; Hideo Harigae
Journal:  Ann Hematol       Date:  2012-09-16       Impact factor: 3.673

5.  [Using target next-generation sequencing assay in diagnosing of 46 patients with suspected congenital anemias].

Authors:  Y Li; G X Peng; Q Y Gao; Y Li; L Ye; J P Li; L Song; H H Fan; Y Yang; Y Z Xiong; Z J Wu; W R Yang; K Zhou; X Zhao; L P Jing; F K Zhang; L Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.